Brand Name
Plegridy
Generic Name
Peginterferon Beta-1A
View Brand Information FDA approval date: August 15, 2014
Classification: Interferon beta
Form: Injection, Kit
What is Plegridy (Peginterferon Beta-1A)?
PLEGRIDY is indicated for the treatment of relapsing forms of multiple sclerosis , to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PLEGRIDY is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis , to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment